ecancer

Editor's Choice for April 2018

Prof Gordon McVie - Founding Editor, ecancer

27 Apr 2018

Neoadjuvant nivolumab for resectable lung cancer

Dr Drew Pardoll - Johns Hopkins Medicine, Baltimore, USA

25 Apr 2018

The importance of online patient groups and 'The ROS1ders'

Janet Freeman-Daily - The ROS1ders

25 Apr 2018

Effects of dasatinib on xenograft lung tumour models with YES1 overexpression

Dr Irati Garmendia - University of Navarra, Pamplona, Spain

25 Apr 2018

Response and safety profile of neoadjuvant nivolumab for resectable lung cancer

Dr Drew Pardoll - Johns Hopkins Medicine, Baltimore, USA

25 Apr 2018

Doubled survival in metastatic lung cancer with combination therapy

Dr Leena Gandhi - NYU Langone Medical Center, New York, USA

25 Apr 2018

Combined immuno-chemotherapy improves survival and responses in metastatic lung cancer

Dr Leena Gandhi - NYU Langone Medical Center, New York, USA

25 Apr 2018

Results from CheckMate-227 : Immune combination reaches PFS endpoint

Dr Matthew Hellmann - Memorial Sloan Kettering Cancer Center, New York, USA

25 Apr 2018

How the SBIR development centre funds cancer initiatives

Michael Weingarten - National Cancer Institute, Rockville, USA

25 Apr 2018

Editor's Choice for February 2018

Prof Gordon McVie - Founding Editor, ecancer

26 Feb 2018

Lung cancer and precision medicine

Dr Pilar Garrido - Universidad de Alcalá, Madrid, Spain

21 Feb 2018

Immuno-oncology in breast and cervical cancer

Prof Neal Ready - Duke University School of Medicine, Durham, USA

29 Jan 2018

More from ecancer